🇺🇸 FDA
Patent

US 6040340

Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors

expired A61KA61K31/198A61K31/223

Quick answer

US patent 6040340 (Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors) held by The Board of Regents, Univ. of Texas System expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents, Univ. of Texas System
Grant date
Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/198, A61K31/223, A61K31/34, A61K31/44